Now showing items 1-2 of 2

    • Clinical development of new drug-radiotherapy combinations. 

      Sharma, RA; Plummer, R; Stock, JK; Greenhalgh, TA; Ataman, O; Kelly, S; Clay, R; Adams, RA; Baird, RD; Billingham, L; Brown, SR; Buckland, S; Bulbeck, H; Chalmers, AJ; Clack, G; Cranston, AN; Damstrup, L; Ferraldeschi, R; Forster, MD; Golec, J; Hagan, RM; Hall, E; Hanauske, A-R; Harrington, KJ; Haswell, T; Hawkins, MA; Illidge, T; Jones, H; Kennedy, AS; McDonald, F; Melcher, T; O'Connor, JPB; Pollard, JR; Saunders, MP; Sebag-Montefiore, D; Smitt, M; Staffurth, J; Stratford, IJ; Wedge, SR; NCRI CTRad Academia-Pharma Joint Working Group (2016-10)
      In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy as part of their treatment, which is one of the most cost-effective cancer treatments. Notably, around 40% of cancer cures ...
    • The transformation of radiation oncology using real-time magnetic resonance guidance: A review. 

      Hall, WA; Paulson, ES; van der Heide, UA; Fuller, CD; Raaymakers, BW; Lagendijk, JJW; Li, XA; Jaffray, DA; Dawson, LA; Erickson, B; Verheij, M; Harrington, KJ; Sahgal, A; Lee, P; Parikh, PJ; Bassetti, MF; Robinson, CG; Minsky, BD; Choudhury, A; Tersteeg, RJHA; Schultz, CJ; MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium
      Radiation therapy (RT) is an essential component of effective cancer care and is used across nearly all cancer types. The delivery of RT is becoming more precise through rapid advances in both computing and imaging. The ...